PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK
Details
- Manufacturer
- IBSA Institut Biochimique SA
- ATC code
- G03DA04
- Status
- 1 aktuell keine Lieferungen
- Reported since
- 6 days
- Expected to be available
- offen
- First report
- 14.05.2026
- Reported by
- Grossist
- Active substance
- progesteronum
- Swissmedic no.
- 6322501
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK is a medication by IBSA Institut Biochimique SA containing the active substance progesteronum (ATC code G03DA04). There is currently a supply shortage that has been ongoing for 6 days. Switzerland has 24 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
progesteronum 25 mg, hydroxypropylbetadexum, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile ad solutionem pro 1.112 ml corresp. natrium 0.05 mg.
Frequently asked questions
What can I do if PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (progesteronum) is often possible. Available alternatives are listed above on this page.
What alternatives exist for PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK?▾
Available alternatives with the same active substance are listed above. progesteronum is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of PROLUTEX INJ LÖS 25 MG/1.112ML DURCHSTF 7 STK?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness